Ernest Mario

Ernest Mario previously served as Chairman and Chief Executive Officer of ALZA Corporation from 1993 to 2001. He currently serves as Chairman of Soleno Therapeutics, Inc. (f/k/a Capnia, Inc.) and on the boards of directors of Celgene Corporation, Eyenovia Inc., and Kindred Biosciences Inc. Dr. Mario previously served on the boards of directors of GlaxoSmithKline plc, Cepheid Inc., Cor Therapeutics, Inc., Millennium Pharmaceuticals, Inc., Sonosite Inc., Catalytica Energy Systems, Inc., Orchid Cellmark, Inc., IntraBiotics Pharmaceuticals, Inc., Alexza Pharmaceuticals, Inc., Pharmaceutical Product Development Inc., Vivus, Inc., XenoPort, Inc., Boston Scientific Corporation, Maxygen, Inc., Chimerix, Inc., and Tonix Pharmaceuticals Holding Corp.